Ocular toxicity of targeted anticancer agents
The proliferation of targeted anticancer agents over the last two decades has revolutionized
cancer treatment and improved survival in many previously refractory malignancies …
cancer treatment and improved survival in many previously refractory malignancies …
Oculofacial plastic surgery in the cancer patient: A narrative review
CE Clabeaux, HS Rana, AH Patadia… - European Journal …, 2024 - journals.sagepub.com
With the advances in systemic therapy and radiotherapy, the life expectancy of patients
battling cancer has increased. The oculofacial plastic surgeon should be aware of the …
battling cancer has increased. The oculofacial plastic surgeon should be aware of the …
Molecularly targeted agents in oculoplastic surgery
RC Allen - Current opinion in ophthalmology, 2017 - journals.lww.com
MTAs represent the future of treatment of oncologic and inflammatory conditions. Application
of these agents to orbital, lacrimal, and eyelid disease will continue to expand. Elucidating …
of these agents to orbital, lacrimal, and eyelid disease will continue to expand. Elucidating …
Xanthelasma palpebrarum: more than meets the eye
S Khode, SHT Tan, EPA Tan, S Uppal - Indian Journal of Otolaryngology …, 2019 - Springer
Xanthelasma palpebrarum (XP) is the most common form of cutaneous xanthomata, and is
important aesthetically, because of its close relation to the eyes, as well as medically for its …
important aesthetically, because of its close relation to the eyes, as well as medically for its …
Cutaneous xanthomas
K Wanat, MH Noe - J. CallenM. W. FreemanA. O. Ofori (Eds.). https …, 2017 - uptodate.com
Cutaneous xanthomas - UpToDate Wolters Kluwer UpToDate English Why UpToDate? Product
Editorial Subscription Options Subscribe Sign in Learn how UpToDate can help you. Select the …
Editorial Subscription Options Subscribe Sign in Learn how UpToDate can help you. Select the …
[PDF][PDF] Nilotinib-induced confluent and reticulated papillomatosis in a patient with chronic myeloid leukemia
A Samal, M Panda, A Biswal - 2023 - cosmoderma.org
Tyrosine kinase inhibitors (TKIs) are anticancer drugs which are being used for the targeted
treatment of various malignancies. Nilotinib is a second-generation TKI used in the treatment …
treatment of various malignancies. Nilotinib is a second-generation TKI used in the treatment …
The Significance of Extracellular Cholesterol Crystals or a Cholesterol Granuloma in Xanthelasma
FA Jakobiec, L Ma, N Wolkow, FC Sutula… - Ocular Oncology and …, 2018 - karger.com
Background/Aims: Xanthelasma is an unreliable indicator of systemic hyperlipidemia. A
review in search of unusual histopathologic features of cellular composition that might …
review in search of unusual histopathologic features of cellular composition that might …